Liposomal bupivacaine alone or combined with tranexamic acid and flurbiprofen axetil for local infiltration analgesia in total hip arthroplasty for displaced femoral neck fractures: a randomized controlled trial
In patients undergoing total hip arthroplasty for displaced femoral neck fractures, local infiltration analgesia with liposomal bupivacaine significantly reduced early postoperative pain and opioid consumption compared to no infiltration, but adding tranexamic acid and flurbiprofen axetil provided no additional analgesic benefit.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For many older adults, a broken hip is a life-altering event. When the bone at the top of the leg, known as the femoral neck, snaps and shifts out of place, the usual treatment is to replace the entire hip joint with a metal and plastic implant. This surgery, called a total hip arthroplasty, allows patients to walk again, but the road to recovery is often paved with significant pain. In the first few days after the operation, the body reacts to the trauma of surgery with inflammation and swelling, making even simple movements like sitting up or taking a step feel like a struggle. If this pain is not managed well, patients may hesitate to move, which slows down their recovery and increases their need for strong painkillers that can cause drowsiness or nausea. Doctors have long sought a way to numb the surgical area directly, injecting a mixture of medicines right into the tissues around the hip to stop pain signals before they reach the brain. One promising tool in this effort is a special form of anesthetic called liposomal bupivacaine. Unlike standard numbing drugs that wear off quickly, this version is packaged in tiny, fatty bubbles that release the medicine slowly over time, acting like a slow-drip faucet of relief rather than a sudden burst.
Researchers recently wondered if they could make this slow-release relief even stronger by mixing it with other common medicines. They considered adding a drug that stops bleeding and another that reduces inflammation, hoping this "cocktail" would tackle pain from every angle. To find out, a team of surgeons and scientists in China set up a careful experiment involving 120 older patients who were all undergoing this specific hip replacement surgery for a broken bone. They divided the patients into three groups. One group received the slow-release numbing drug alone. A second group received the same drug mixed with the bleeding-stopping and inflammation-reducing medicines. The third group, serving as a baseline for comparison, received no local numbing injection at all, relying only on standard pain management after the surgery. The goal was to see if the extra ingredients provided any real benefit over the slow-release drug by itself.
The results showed that the slow-release numbing drug worked very well on its own. Patients who received it, whether alone or mixed with the other drugs, reported significantly less pain when they were resting and when they were moving around compared to those who received no local injection. This difference was most noticeable in the first two days after surgery. During this critical window, the patients with the local injection needed less of the strong opioid pain medication to feel comfortable. Specifically, over the first three days, the groups with the injection used roughly 26 milligrams of morphine-equivalent pain medication, while the group without the injection used about 37 milligrams. This reduction in strong painkillers is a meaningful victory, as it helps patients stay alert and active during their recovery.
However, the study found that adding the extra medicines did not make the pain relief any better. The group that received the "cocktail" of the slow-release drug plus the bleeding and inflammation fighters felt exactly the same amount of pain as the group that received the slow-release drug alone. There was no statistical advantage to the mixture. The patients in both treated groups moved their hips with similar ease, slept with similar quality, and had similar rates of complications like nausea or infection. The researchers concluded that while the slow-release numbing drug is a powerful tool for managing early pain after hip surgery, the addition of the other two medicines did not provide any extra help. The extra ingredients did not hurt, but they did not help either, suggesting that for this specific type of surgery, the single drug is sufficient to provide the best early comfort without the need for a more complex mixture.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.